date,title,source
Oct-22-18,"Neovasc Announces Successful Tiara ""Live Case"" at the 32nd Annual EACTS 2018 Meeting",PR Newswire
Oct-23-18,3 Healthcare Stocks To Watch On Tuesday,ACCESSWIRE
Oct-23-18,Neovasc Broadcasts Surgery With Mitral Valve Device Live At Medical Conference,Benzinga
Nov-07-18,Neovasc Announces Third Quarter 2018 Financial Results Conference Call and Webcast,PR Newswire
Nov-07-18,Neovasc Announces Third Quarter 2018 Financial Results Conference Call and Webcast,CNW Group
Nov-14-18,Neovasc: 3Q Earnings Snapshot,Associated Press
Nov-14-18,Neovasc Announces Third Quarter 2018 Financial Results,CNW Group
Nov-14-18,Neovasc Q3 Earnings Preview,Benzinga
Nov-15-18,Today's Research Reports on Trending Tickers: Neovasc and Acadia Healthcare,ACCESSWIRE
Nov-20-18,JACC: Cardiovascular Interventions Publishes Peer Reviewed Article on Neovasc Reducer Patient Case,PR Newswire
Dec-11-18,Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer as Published in JACC,PR Newswire
Dec-21-18,Neovasc Receives ISO 13485: 2016 Certification,CNW Group
Jan-03-19,Neovasc Receives Nasdaq Notification Regarding Minimum Market Value Deficiency,CNW Group
Jan-14-19,Neovasc Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency,CNW Group
Jan-22-19,4 Healthcare Stocks Looking to Set the Pace on Tuesday (1/22/19),ACCESSWIRE
Jan-22-19,Neovasc Announces Dismissal of Claim brought by Edwards Lifesciences,CNW Group
Jan-23-19,4 Healthcare Stocks Making Moves On Wednesday (1/23/19),ACCESSWIRE
Jan-23-19,"Neovasc, Litigation Information and Product Reviews",ACCESSWIRE
Jan-23-19,Neovasc announces peer reviewed publication in JACC demonstrating objective evidence of improvement in perfusion after Reducer implantation,CNW Group
Jan-29-19,These 4 Healthcare Stocks Healthy With Potential Opportunities,ACCESSWIRE
Jan-29-19,Neovasc Receives Approval to Proceed with Phase 2 of TIARA-II Study from Clinical Regulators in Germany and the UK,CNW Group
Jan-30-19,Neovasc Announces Renewal of German NUB Status 1 Designation for Neovasc Reducer Procedure for Treatment of Refractory Angina,CNW Group
Feb-11-19,Pierangeli Clinic Initiates Program Providing Neovasc Reducer Procedure to Italian Patients with Refractory Angina,CNW Group
Feb-20-19,Neovasc Provides Corporate Update,CNW Group
Feb-21-19,Neovasc Celebrates 5-Year Anniversary of Tiara Patient as the Longest Surviving Transcatheter Mitral Valve Replacement in the World,PR Newswire
Feb-22-19,"Neovasc Announces Refiling of Interim Financial Statements and Management's Discussion and Analysis for the Period Ended September 30, 2018",CNW Group
Feb-25-19,Neovasc Announces Proposed Public Offering of Common Shares,CNW Group
Feb-26-19,Neovasc Announces Pricing of $5 Million Public Offering of Common Shares,PR Newswire
Feb-26-19,Neovasc Announces Pricing of $5 Million Public Offering of Common Shares,CNW Group
Feb-27-19,Neovasc to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference,CNW Group
Feb-28-19,Neovasc announces closing of $5 million public offering of common shares,CNW Group
Mar-04-19,Neovasc's Tiara Mitral Valve Replacement Technology Featured in Update Presentation at the CRT 2019 Meeting,CNW Group
Mar-05-19,"Neovasc Announces Reducer Implant ""Live Case"" at the CRT Meeting in Washington, DC",CNW Group
Mar-12-19,Neovasc Announces Proposed Public Offering of Common Shares,CNW Group
Mar-12-19,Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares,PR Newswire
Mar-13-19,"Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21",CNW Group
Mar-13-19,"The Daily Biotech Pulse: AEterna Zentaris Explores Options, Verastem Plunges On Weak Copiktra Sales, FDA Nod For Aerie",Benzinga
Mar-13-19,Neovasc Announces Pricing of $5 Million Public Offering of Common Shares,PR Newswire
Mar-14-19,Neovasc Completes Successful Quality System Surveillance Audit,PR Newswire
Mar-15-19,Neovasc Announces Closing of $5 Million Public Offering of Common Shares,CNW Group
Mar-19-19,Reducer Featured in Presentation at American College of Cardiology's Annual Meeting,PR Newswire
Mar-19-19,Reducer Featured in Presentation at American College of Cardiology's Annual Meeting,CNW Group
Mar-21-19,Neovasc: 4Q Earnings Snapshot,Associated Press
Mar-21-19,Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results,PR Newswire
Mar-21-19,Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results,CNW Group
Mar-21-19,Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara,PR Newswire
Apr-17-19,Neovasc Announces Resolution of Last Remaining Active Litigation,CNW Group
Apr-17-19,Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer Improves Diastolic Function in patients suffering from severe angina,PR Newswire
Apr-26-19,"Neovasc Provides Highlights from Annual Conference of the DGK, the German Society of Cardiology; Symposium Generates Growing Support for Reducer",PR Newswire
Apr-26-19,"Neovasc Provides Highlights from Annual Conference of the DGK, the German Society of Cardiology; Symposium Generates Growing Support for Reducer",CNW Group
May-03-19,"Neovasc to Announce First Quarter 2019 Financial Results on Thursday, May 9th",PR Newswire
May-03-19,"Neovasc to Announce First Quarter 2019 Financial Results on Thursday, May 9th",CNW Group
May-06-19,"Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer",PR Newswire
May-06-19,"Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer",CNW Group
May-09-19,Neovasc: 1Q Earnings Snapshot,Associated Press
May-09-19,Neovasc Announces First Quarter 2019 Financial Results,CNW Group
May-14-19,Neovasc Announces Private Placement of Convertible Debt and Equity for Gross Proceeds of US$11.5 Million,PR Newswire
May-16-19,Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million,PR Newswire
May-22-19,Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer in a Peer Reviewed Article in the International Journal of Cardiology,PR Newswire
May-23-19,New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris,PR Newswire
May-23-19,New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris,CNW Group
May-23-19,"The Daily Biotech Pulse: Breakthrough Therapy Designation For Iovance, Guardant Prices Offering, 2 Stocks to Debut",Benzinga
